Showing results (671-680 of 1,837) with videos related to
Sort By:
Pageof 184
ESMO Open|January 30, 2021
A prospective cohort study on the safety of checkpoint inhibitors in older cancer patients - the ELDERS studyF Gomes, P Lorigan, S Woolley, et al.ESMO Open|January 30, 2021
Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancerP Heudel, S Chabaud, D Perol, et al.ESMO Open|September 27, 2019
Elevated CRP levels indicate poor progression-free and overall survival on cancer patients treated with PD-1 inhibitorsSanna Iivanainen, Jarkko Ahvonen, Aija Knuuttila, et al.ESMO Open|September 27, 2019
Ex vivo lung cancer spheroids resemble treatment response of a patient with NSCLC to chemotherapy and immunotherapy: case report and translational studyRaimondo Di Liello, Vincenza Ciaramella, Giusi Barra, et al.ESMO Open|September 27, 2019
How I treat squamous ENT cancerMarco Carlo Merlano, Nerina Denaro, Danilo Galizia, et al.ESMO Open|February 18, 2021
Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)C De Angelis, D Bruzzese, A Bernardo, et al.ESMO Open|February 8, 2021
A matching-adjusted indirect comparison of combination nivolumab plus ipilimumab with BRAF plus MEK inhibitors for the treatment of BRAF-mutant advanced melanoma☆A A Tarhini, K Toor, K Chan, et al.ESMO Open|August 28, 2020
Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysisMariana Brandão, Christian Maurer, Patricia Klarmann Ziegelmann, et al.ESMO Open|August 28, 2020
Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre studyAnastasia Constantinidou, Nicolas Sauve, Silvia Stacchiotti, et al.Pageof 184